Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Max J. Korman
Are PCSK9 Inhibitors Cost Effective?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Related publications
PCSK9 Peptide Inhibitors
Science-Business eXchange
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors
INNOVATIONS in pharmacy
PCSK9 Inhibitors: When Statins Aren't Enough
Prescriber
Pharmacology
PCSK9 Inhibitors: A Technology Worth Paying For?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice
Postgraduate Medicine
Medicine
How Cost-Effective Are New Cancer Drugs in the U.S.?
Expert Review of Pharmacoeconomics and Outcomes Research
Medicine
Health Policy
Pharmacology
Metered Dose Inhalers Are Most Cost Effective for Asthma Drugs
BMJ
Are Expansions Cost Effective for Stock Exchanges? A Global Perspective
Journal of Banking and Finance
Economics
Econometrics
Finance